References
Hamman R, Werner H, Krasemann C, Rummel HJ. β-Lactamase activity of intestinal saccarolytic Bacteroides spp. and members of the H. mclaninogenicus and B. oralis groups determined by substrate profile. In Nelson & Grassi (Eds) Current chemotherapy and infectious disease, pp. 756–758. American Society for Microbiology. Washington. 1980
Jones RN, Barry AL, Fuchs PC. Thornsberry C. Collaborative in vitro investigations of sulbactam/ampicillin against clinically relevant bacterial pathogens in the United States. Proceedings of the 13th International Congress of Chemotherapy. Vienna. August 28–September 2, 1983. Abstract no. 23/7-23/11. 1983
Kager L, Malmborg AS, Sjostedt S, Nord CE. Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. European Journal of Clinical Microbiology 2: 559–563. 1983
Retsema JA, English AR. Girard AE. Anderson M, Brennan L, et al. Sulbactam and ampicillin: synergistic antibacterial activity against hospital isolates of Enterobacteriaceae. methicillin-resistant Staphylococcus, and anaerobes. Proceedings of the 13th International Congress of Chemotherapy, Vienna. August 28–September 2, 1983. Abstract no. 23/1-23/5, 1983
Werner H. Seplikämie-Endokarditis. In Werner (Ed.) Anaerobier-Infektionen. Pathogenese. Klinik, Therapie. Diagnostik, pp. 86-88, Georg Thieme Verlag, Stuttgart. 1985
Wexler HM, Harris B. Carter W, Finegold SM. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 27: 876–878, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heilmann, F., Heizmann, W. & Werner, H. Ampicillin plus Sulbactam. Drugs 35 (Suppl 7), 84–88 (1988). https://doi.org/10.2165/00003495-198800357-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800357-00019